Published in J Clin Invest on October 01, 1985
Emergency management of meningococcal disease. Arch Dis Child (1999) 3.93
Mechanisms of cardiac and renal dysfunction in patients dying of sepsis. Am J Respir Crit Care Med (2013) 3.25
Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med (1989) 2.69
Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med (1996) 2.50
Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium. Br J Pharmacol (1992) 2.09
LPS-induced autophagy is mediated by oxidative signaling in cardiomyocytes and is associated with cytoprotection. Am J Physiol Heart Circ Physiol (2008) 1.97
Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. J Clin Invest (1989) 1.87
Clinical review: Myocardial depression in sepsis and septic shock. Crit Care (2002) 1.74
Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest (1995) 1.55
Changes in B-type Natriuretic Peptide and Related Hemodynamic Parameters Following a Fluid Challenge in Critically Ill Patients with Severe Sepsis or Septic Shock. Indian J Crit Care Med (2017) 1.40
Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity. CMAJ (2005) 1.36
Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock. J Clin Invest (1986) 1.34
An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction. J Exp Med (2005) 1.29
Septic cardiomyopathy. Ann Intensive Care (2011) 1.27
The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J Clin Invest (1992) 1.22
Sepsis-induced cardiomyopathy. Curr Cardiol Rev (2011) 1.21
Molecular events in the cardiomyopathy of sepsis. Mol Med (2008) 1.18
Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann Surg (1991) 1.12
Cardiovascular response to dobutamine stress predicts outcome in severe sepsis and septic shock. Crit Care (2008) 1.07
The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta. J Clin Invest (1995) 1.05
Toll-like receptors: new players in myocardial ischemia/reperfusion injury. Antioxid Redox Signal (2011) 1.04
Complement dependency of cardiomyocyte release of mediators during sepsis. FASEB J (2011) 0.96
Quercetin reduces inflammatory responses in LPS-stimulated cardiomyoblasts. Oxid Med Cell Longev (2012) 0.90
Blockade of exosome generation with GW4869 dampens the sepsis-induced inflammation and cardiac dysfunction. Biochim Biophys Acta (2015) 0.89
Elevated cardiac troponin I in sepsis and septic shock: no evidence for thrombus associated myocardial necrosis. PLoS One (2010) 0.89
Sepsis-induced myocardial dysfunction: pathophysiology and management. J Intensive Care (2016) 0.89
A review of sepsis-induced cardiomyopathy. J Intensive Care (2015) 0.88
Tumour necrosis factor alpha gene polymorphism: a predisposing factor to non-ischaemic myocardial dysfunction? Heart (2002) 0.88
The role of nitric oxide in experimental murine sepsis due to pyrogenic exotoxin A-producing Streptococcus pyogenes. Infect Immun (1997) 0.88
Right ventricular dysfunction in patients with septic shock. Intensive Care Med (1988) 0.85
Effects of tumour necrosis factor-alpha on left ventricular function in the rat isolated perfused heart: possible mechanisms for a decline in cardiac function. Br J Pharmacol (1999) 0.84
Role of complement in multiorgan failure. Clin Dev Immunol (2012) 0.83
Rac1 activation induces tumour necrosis factor-α expression and cardiac dysfunction in endotoxemia. J Cell Mol Med (2010) 0.82
Mitogen-activated protein kinase phosphatase-1 inhibits myocardial TNF-α expression and improves cardiac function during endotoxemia. Cardiovasc Res (2011) 0.82
Severe postpartum sepsis with prolonged myocardial dysfunction: a case report. J Med Case Rep (2010) 0.82
Widespread Down-Regulation of Cardiac Mitochondrial and Sarcomeric Genes in Patients With Sepsis. Crit Care Med (2017) 0.82
[Heart in sepsis : Molecular mechanisms, diagnosis and therapy of septic cardiomyopathy]. Anaesthesist (2017) 0.82
Cardiac Troponin Release is Associated with Biomarkers of Inflammation and Ventricular Dilatation During Critical Illness. Shock (2016) 0.81
Cardiovascular Dysfunction in Sepsis and Septic Shock. Curr Treat Options Cardiovasc Med (2000) 0.81
IκB Kinase Inhibitor Attenuates Sepsis-Induced Cardiac Dysfunction in CKD. J Am Soc Nephrol (2016) 0.80
Down but not out: myocardial depression in sepsis. Crit Care (2012) 0.80
Do cardiomyocytes mount an immune response to Group A Streptococcus? Cytokine (2011) 0.80
Mesenteric lymph from rats with trauma-hemorrhagic shock causes abnormal cardiac myocyte function and induces myocardial contractile dysfunction. J Appl Physiol (1985) (2011) 0.79
Gender dimorphism of the cardiac dysfunction in murine sepsis: signalling mechanisms and age-dependency. PLoS One (2014) 0.79
The haemodynamics of septic shock. Intensive Care Med (1990) 0.78
Multiple organ dysfunction syndrome in humans and animals. J Vet Intern Med (2014) 0.78
Elucidating the role of reversible protein phosphorylation in sepsis-induced myocardial dysfunction. Shock (2009) 0.78
Characterization of human septic sera induced gene expression modulation in human myocytes. Int J Clin Exp Med (2009) 0.78
Thrombopoietin as biomarker and mediator of cardiovascular damage in critical diseases. Mediators Inflamm (2012) 0.78
Assessment of the intrinsic contractile status of the heart during sepsis by myocardial pressure-dimension analysis. Ann Surg (1988) 0.76
Use of insulin to decrease septic shock-induced myocardial depression in a porcine model. Inflammation (2013) 0.76
Sepsis: clinical dilemmas. Yale J Biol Med (2000) 0.76
Are platelets a 'forgotten' source of sepsis-induced myocardial depressing factor(s)? Crit Care (2008) 0.75
Septic shock and sepsis syndrome in obstetric patients. Infect Dis Obstet Gynecol (1994) 0.75
Low systemic vascular resistance: differential diagnosis and outcome. Crit Care (1999) 0.75
Myocardial oxidative stress correlates with left ventricular dysfunction on strain echocardiography in a rodent model of sepsis. Intensive Care Med Exp (2017) 0.75
Cardiorespiratory control and cytokine profile in response to heat stress, hypoxia, and lipopolysaccharide (LPS) exposure during early neonatal period. Physiol Rep (2016) 0.75
Transient severe myocardial ischemia during septic shock in a young woman with AIDS. J Natl Med Assoc (1995) 0.75
Cardiomyopathy associated with high-dose interleukin-2 therapy. West J Med (1991) 0.75
Levosimendan for Septic Myocardial Dysfunction: Not Yet Ready for Prime Time. Crit Care Med (2015) 0.75
Salvaging the septic heart through targeting the interleukin-6/p38 mitogen-activated protein kinase signaling network. Crit Care Med (2011) 0.75
Sepsis in Pediatric Cardiac Intensive Care. Pediatr Crit Care Med (2016) 0.75
Complement and sepsis-induced heart dysfunction. Mol Immunol (2016) 0.75
Sepsis-induced cardiac dysfunction and β-adrenergic blockade therapy for sepsis. J Intensive Care (2017) 0.75
Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med (1984) 3.81
Real-time radionuclide cineangiography in the noninvasive evaluation of global and regional left ventricular function at rest and during exercise in patients with coronary-artery disease. N Engl J Med (1977) 2.94
Patterns of septic shock in man--a detailed study of 56 patients. Ann Surg (1967) 2.79
Studies on the circulatory changes in the dog produced by endotoxin from gram-negative microorganisms. J Clin Invest (1956) 2.76
Abnormal vascular tone, defective oxygen transport and myocardial failure in human septic shock. Ann Surg (1967) 2.65
Regulation of spontaneous activity and growth of embryonic chick heart cells in tissue culture. Dev Biol (1967) 2.59
Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma. N Engl J Med (1983) 2.49
HEMODYNAMIC AND METABOLIC STUDIES ON SHOCK ASSOCIATED WITH BACTEREMIA. OBSERVATIONS ON 16 PATIENTS. Ann Intern Med (1965) 2.49
Bacteremia due to gram-negative bacilli other than the Salmonella; a clinical and therapeutic study. AMA Arch Intern Med (1951) 2.47
Type-specific and cross-reactive antibodies in gram-negative bacteremia. N Engl J Med (1972) 2.42
Editorial: Gram-negative-rod bacteremia. N Engl J Med (1974) 2.36
In vitro studies on single beating rat heart cells. I. Growth and organization. Exp Cell Res (1963) 1.98
Hemodynamic studies and results of therapy in 50 patients with bacteremic shock. Am J Med (1973) 1.85
In vitro studies of single isolated beating heart cells. Science (1960) 1.74
Survival in medically treated coronary artery disease. Circulation (1979) 1.46
Hemodynamic and metabolic studies on shock associated with gram negative bacteremia. Medicine (Baltimore) (1973) 1.16
Myocardial depression during sepsis. Am J Surg (1977) 1.13
Inotropic effects and changes in sodium and calcium contents associated with inhibition of monovalent cation active transport by ouabain in cultured myocardial cells. J Gen Physiol (1979) 1.12
Circulating factors in the etiology of pulmonary insufficiency and right heart failure accompanying severe sepsis (peritonitis). Ann Surg (1970) 1.11
Role of a myocardial depressant factor in the pathogenesis of circulatory shock. Fed Proc (1971) 1.11
Origin of myocardial depressant factor in shock. Am J Physiol (1970) 1.09
Recording system for monitoring automaticity of heart cells in culture. Nature (1971) 0.97
Inotropic effects of different calcium ion concentration on the embryonic chick ventricle. Comparison of single cultured cells and intact muscle strips. Circ Res (1975) 0.92
Is there a humoral factor that depresses ventricular function in sepsis? Circ Shock Suppl (1979) 0.90
Studies in vitro on single beating rat heart cells. IX. The restoration of beating by serum lipids and fatty acids. Biochim Biophys Acta (1966) 0.89
The pathophysiologic role of myocardial depressant factor as a mediator of circulatory shock. Klin Wochenschr (1982) 0.88
An assessment of myocardial function in human sepsis utilizing ECG gated cardiac scintigraphy. Chest (1981) 0.86
Reversal by calcium of rat heart cell dysfunction induced by human sera in septic shock. Circ Shock (1979) 0.86
Measurement of the rate and velocity of movement by single heart cells in culture. Am J Cardiol (1973) 0.85
Effects of a myocardial depressant factor on isolated vascular smooth muscle. Am J Physiol (1971) 0.85
Spectrum of cardiovascular function during gram-negative sepsis. Prog Cardiovasc Dis (1981) 0.85
Myocardial function in endotoxin shock. Circ Shock Suppl (1979) 0.82
Inhibited response to isoproterenol and altered action potential of beating rat heart cells by human serum in septic shock. Circ Shock (1978) 0.81
Plasma myocardial depressant activity (shock factor) identified as salt in the cat papillary muscle bioassay system. J Trauma (1973) 0.81
Isolation of myocardial depressant factor from plasma of dogs in hemorrhagic shock. Biochim Biophys Acta (1977) 0.80
Cardiovascular dysfunction in septic shock: new insights into a deadly disease. Int J Cardiol (1985) 0.80
Efficacy and safety of intravenous midazolam and ketamine as sedation for therapeutic and diagnostic procedures in children. Pediatrics (1997) 15.08
Prospective evaluation of a monoclonal antibody in diagnosis of Pneumocystis carinii pneumonia. Lancet (1986) 5.65
Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med (1990) 5.15
The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med (1989) 4.24
Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med (1984) 3.81
CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med (1989) 3.13
Bacteremia due to Mycobacterium avium-intracellulare in the acquired immunodeficiency syndrome. Ann Intern Med (1983) 3.06
The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective study of 26 patients, with review of the literature. Am J Med (1979) 2.86
Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med (1989) 2.69
Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med (1996) 2.50
A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med (1989) 2.45
Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans. Proc Natl Acad Sci U S A (2000) 2.41
Diagnosis of Pneumocystis carinii pneumonia: improved detection in sputum with use of monoclonal antibodies. N Engl J Med (1988) 2.33
Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis. Am J Respir Crit Care Med (1995) 2.31
Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med (1989) 2.21
Repair and mutagenesis of the genome of a deletion mutant of the coronavirus mouse hepatitis virus by targeted RNA recombination. J Virol (1992) 2.20
Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med (1987) 2.05
Monoclonal antibodies to Pneumocystis carinii: identification of specific antigens and characterization of antigenic differences between rat and human isolates. J Infect Dis (1989) 2.04
Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery. J Clin Invest (2001) 2.03
Ultrasound guidance improves the success rate of internal jugular vein cannulation. A prospective, randomized trial. Chest (1990) 2.02
Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med (1997) 2.00
Detection of Pneumocystis carinii by fluorescent-antibody stain using a combination of three monoclonal antibodies. J Clin Microbiol (1987) 1.90
Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. Crit Care Med (1987) 1.89
Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro. Am Rev Respir Dis (1982) 1.89
The diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome using subsegmental bronchoalveolar lavage. Am Rev Respir Dis (1984) 1.88
Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. J Clin Invest (1989) 1.87
Kaposi's sarcoma causing pulmonary infiltrates and respiratory failure in the acquired immunodeficiency syndrome. Ann Intern Med (1985) 1.86
The coronary circulation in human septic shock. Circulation (1986) 1.83
Takayasu's arteritis and its therapy. Ann Intern Med (1985) 1.82
Identification of antigens and antibodies specific for Pneumocystis carinii. J Immunol (1988) 1.81
Characterization of a monoclonal antibody that defines an immunoregulatory T cell subset for immunoglobulin synthesis in humans. Proc Natl Acad Sci U S A (1980) 1.81
Relative role of heme nitrosylation and beta-cysteine 93 nitrosation in the transport and metabolism of nitric oxide by hemoglobin in the human circulation. Proc Natl Acad Sci U S A (2000) 1.81
Mechanisms of glucocorticoid action on immune processes. Annu Rev Pharmacol Toxicol (1979) 1.67
Induced sputum to diagnose Pneumocystis carinii pneumonia in immunosuppressed pediatric patients. J Pediatr (1989) 1.63
Leukotriene B4 and interleukin-8 in human immunodeficiency virus-related pulmonary disease. Chest (1993) 1.62
Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death. Circulation (2001) 1.62
Adult respiratory distress syndrome in patients with severe neutropenia. N Engl J Med (1986) 1.60
A controlled trial of HA-1A in a canine model of gram-negative septic shock. JAMA (1993) 1.59
G-CSF during Escherichia coli versus Staphylococcus aureus pneumonia in rats has fundamentally different and opposite effects. Am J Respir Crit Care Med (1999) 1.58
Therapy of the hypereosinophilic syndrome. Ann Intern Med (1978) 1.58
Prevalent myocarditis at necropsy in the acquired immunodeficiency syndrome. J Am Coll Cardiol (1988) 1.57
Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility. Am J Physiol (1999) 1.55
Validated risk stratification model accurately predicts low risk in patients with unstable angina. J Am Coll Cardiol (2000) 1.54
Effects of arachidonic acid, monohydroxyeicosatetraenoic acid and prostaglandins on the release of mucous glycoproteins from human airways in vitro. J Clin Invest (1981) 1.52
A lipid A analog, E5531, blocks the endotoxin response in human volunteers with experimental endotoxemia. Crit Care Med (2000) 1.50
Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients. J Clin Oncol (1987) 1.50
Clinical predictors easily obtained at presentation predict resource utilization in unstable angina. Am Heart J (1998) 1.49
A randomized, blinded, prospective trial to compare the safety and efficacy of three bowel-cleansing solutions for colonoscopy (HSG-01*). Endoscopy (2003) 1.48
Nitric oxide synthase inhibition increases venular leukocyte rolling and adhesion in septic rats. Crit Care Med (2000) 1.48
Intron mobility in phage T4 occurs in the context of recombination-dependent DNA replication by way of multiple pathways. Genes Dev (1996) 1.48
Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Am Rev Respir Dis (1987) 1.47
Human eosinophils. Purification and cytotoxic capability of eosinophils from patients with the hypereosinophilic syndrome. Blood (1978) 1.46
Simultaneous intracoronary ultrasound and Doppler flow studies distinguish flow-mediated from receptor-mediated endothelial responses. Catheter Cardiovasc Interv (1999) 1.46
Effect of 100% oxygen administration on infarct size and left ventricular function in a canine model of myocardial infarction and reperfusion. Am Heart J (1995) 1.45
Characterization of de novo folate synthesis in Pneumocystis carinii and Toxoplasma gondii: potential for screening therapeutic agents. J Infect Dis (1989) 1.44
Peak systolic pressure/end-systolic volume ratio, a load-independent measure of ventricular function, is reversibly decreased in human septic shock. Crit Care Med (1994) 1.43
Myocardial dysfunction in septic shock. Crit Care Clin (2000) 1.42
Effects of epinephrine and amrinone on contractility and cyclic adenosine monophosphate generation of tumor necrosis factor alpha-exposed cardiac myocytes. Crit Care Med (1999) 1.42
Does low individual operator coronary interventional procedural volume correlate with worse institutional procedural outcome? J Am Coll Cardiol (1997) 1.41
Nonspecific interstitial pneumonitis: a common cause of pulmonary disease in the acquired immunodeficiency syndrome. Ann Intern Med (1987) 1.41
Characterization of a hyperdynamic murine model of resuscitated sepsis using echocardiography. Am J Respir Crit Care Med (2001) 1.40
Prognostic factors in sepsis: the cold facts. Crit Care Med (1992) 1.40
The effects of heterologous platelet transfusion on pulmonary function during ARDS. Chest (1990) 1.39
Validation of computerized three-dimensional reconstruction of intravascular ultrasound: measurements of absolute luminal diameter and cross-sectional area in ex vivo human coronary arteries. J Invasive Cardiol (1992) 1.39
Immunologic and neuropharmacologic stimulation of mucous glycoprotein release from human airways in vitro. J Clin Invest (1980) 1.39
Discordant epicardial and microvascular endothelial responses in heart transplant recipients early after transplantation. J Heart Lung Transplant (1998) 1.39
Response of the septic vasculature to prolonged vasopressor therapy with N(omega)-monomethyl-L-arginine and epinephrine in canines. Crit Care Med (1998) 1.39
Pioglitazone initiation and subsequent hospitalization for congestive heart failure. Diabet Med (2005) 1.38
Tumor necrosis factor-alpha induces mucin hypersecretion and MUC-2 gene expression by human airway epithelial cells. Am J Respir Cell Mol Biol (1995) 1.38
Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest (1990) 1.38
Cost and appropriateness of radionuclide exercise stress testing by cardiologists and non-cardiologists. Am J Cardiol (1996) 1.38
On-site physician staffing in a community hospital intensive care unit. Impact on test and procedure use and on patient outcome. JAMA (1984) 1.37
Disseminated Mycobacterium haemophilum infection in two patients with the acquired immunodeficiency syndrome. Am J Med (1988) 1.36
Human monoclonal anti-keyhole limpet hemocyanin antibody-secreting hybridoma produced from peripheral blood B lymphocytes of a keyhole limpet hemocyanin-immune individual. J Exp Med (1982) 1.36
Alpha-adrenergic hyper-responsiveness in asthma. N Engl J Med (1979) 1.35
A circulating myocardial depressant substance is associated with cardiac dysfunction and peripheral hypoperfusion (lactic acidemia) in patients with septic shock. Chest (1989) 1.34
Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock. J Clin Invest (1986) 1.34
Nonspecific interstitial pneumonitis without evidence of Pneumocystis carinii in asymptomatic patients infected with human immunodeficiency virus (HIV). Ann Intern Med (1988) 1.32
Potent effect of trimetrexate, a lipid-soluble antifolate, on Toxoplasma gondii. J Infect Dis (1987) 1.29
Endocarditis due to resistant viridans streptococci during oral penicillin chemoprophylaxis. N Engl J Med (1979) 1.29